A61K 31/538
Ortho- or peri-condensed with carbocyclic ring systems
Official title: ortho- or peri-condensed with carbocyclic ring systems
A61K31/538 (Ortho- or peri-condensed with carbocyclic ring systems) appears on 622 US grants and 1,177 published applications in this corpus.
Search patents in A61K- Granted patents
- 622
- Published applications
- 1,177
- Assignees
- 506
- Inventors
- 3,082
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 3 | 0 |
| 1998 | 5 | 0 |
| 1999 | 3 | 0 |
| 2000 | 7 | 0 |
| 2001 | 8 | 3 |
| 2002 | 10 | 10 |
| 2003 | 8 | 26 |
| 2004 | 7 | 36 |
| 2005 | 4 | 25 |
| 2006 | 15 | 44 |
| 2007 | 8 | 40 |
| 2008 | 18 | 27 |
| 2009 | 21 | 42 |
| 2010 | 26 | 41 |
| 2011 | 13 | 28 |
| 2012 | 29 | 44 |
| 2013 | 40 | 64 |
| 2014 | 40 | 66 |
| 2015 | 51 | 73 |
| 2016 | 36 | 67 |
| 2017 | 48 | 63 |
| 2018 | 44 | 55 |
| 2019 | 43 | 41 |
| 2020 | 30 | 42 |
| 2021 | 16 | 46 |
| 2022 | 25 | 33 |
| 2023 | 15 | 41 |
| 2024 | 18 | 57 |
| 2025 | 19 | 91 |
| 2026 | 12 | 72 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Benzoxazinone derivatives as selective cytotoxic agents15 Sep 2026US 12,735,409 B2Merck Sharp & Dohme Corp.
- Bacterial DNA gyrase inhibitors and methods of use thereof25 Aug 2026US 12,714,692 B2The Florida International University Board of Trustees
- Calcineurin inhibitors of the setron family for the treatment of hearing loss11 Aug 2026US 12,702,671 B2Sensorion
- Methods of controlling and improving brain health28 Jul 2026US 12,691,124 B2Icahn School of Medicine at Mount Sinai
- Medicament for preventing and/or treating dry eye14 Jul 2026US 12,678,443 B2Boehringer Ingelheim International GmbH
- Substituted oxoisoindolinyl piperidine-2,6-dione compounds and aza analogs thereof8 Oct 2026US 2026/0308147 A1
- Long-term prevention and/or treatment of a disease by slo-1 inhibitors1 Oct 2026US 2026/0294890 A1
- Methods of treating cancer with inhibitors of fn141 Oct 2026US 2026/0294916 A1
- Benzo-fused ring compound inhibitor, and preparation method therefor and use thereof1 Oct 2026US 2026/0297071 A1Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Controlling homeostatic regulatory circuitry in hypothalamus24 Sep 2026US 2026/0284071 A1The Johns Hopkins University
Most cited
By later US patents
- 6-amino-1,4-dihydro-benzo[d][1,3] oxazin-2-ones and analogs useful as progesterone receptor modulators251US 7,247,625 B2Wyeth · 2007
- Intermediates useful for making 2,4-pyrimidinediamine compounds192US 7,060,827 B2Rigel Pharmaceuticals, Inc. · 2006
- 2,4-disubstituted pyrimidines useful as kinase inhibitors178US 8,338,439 B2Celgene Avilomics Research, Inc. · 2012
- Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds176US 7,122,542 B2Rigel Pharmaceuticals, Inc. · 2006
- 2,4-pyrimidinediamine compounds and their uses176US 7,557,210 B2Rigel Pharmaceuticals, Inc. · 2009